Fundraising Fox
Skeletalis
4 known investors
Find your way into Skeletalis
Sign up to see every warm intro you have to Skeletalis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Skeletalis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling. The company translates bone biology research into therapies designed to protect and rebuild bone.
Investors · 4
How we know: age1's portfolio page · futurefemhealth.com · Not right? Tell us
How we know: Pillar VC's portfolio page · funding news · futurefemhealth.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$8M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountseedNov 2025
Pillar VC (lead), age1, KdT Ventures, Slocum Management
Source ↗ - $8MraisedNov 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Skeletalis do?
- Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling. The company translates bone biology research into therapies designed to protect and rebuild bone.
- Who are Skeletalis's investors?
- Skeletalis's investors include age1, Pillar VC, KdT Ventures.
- How much funding has Skeletalis raised?
- Skeletalis has disclosed $8M raised across 1 of its 2 known rounds.